Researchers develop synthetic compound that may lead to drugs to fight pancreatic, lung cancer
Researchers at UT Southwestern Medical Center have identified a chemical compound that may eventually lead to a drug that fights cancers that are dependent on a particular anti-viral enzyme for growth.